Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Coated – impregnated – or colloidal particulate
Reexamination Certificate
2005-12-16
2008-03-18
Jones, D. L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Coated, impregnated, or colloidal particulate
C424S001110, C424S001370, C424S001650, C424S009300, C424S009321, C534S015000
Reexamination Certificate
active
07344698
ABSTRACT:
Emulsions preferably of nanoparticles formed from high boiling liquid perfluorochemical substances, said particles coated with a lipid/surfactant coating are made specific to regions of activated endothelial cells by coupling said nanoparticles to a ligand specific for αvβ3integrin, other than an antibody. The nanoparticles may further include biologically active agents, radionuclides, or other imaging agents.
REFERENCES:
patent: 5520904 (1996-05-01), Nosco et al.
patent: 5571498 (1996-11-01), Cacheris et al.
patent: 5614170 (1997-03-01), Cacheris et al.
patent: 5690907 (1997-11-01), Lanza et al.
patent: 5780010 (1998-07-01), Lanza et al.
patent: 5958371 (1999-09-01), Lanza et al.
patent: 5989520 (1999-11-01), Lanza et al.
patent: 6130231 (2000-10-01), Wityak et al.
patent: 6153628 (2000-11-01), Jin et al.
patent: 6322770 (2001-11-01), Rajopadhye et al.
patent: 7138104 (2006-11-01), Carpenter, Jr.
patent: 2002/0127182 (2002-09-01), Sherry et al.
patent: WO-99/58162 (1999-11-01), None
patent: WO-00/35488 (2000-06-01), None
patent: WO-00/35492 (2000-06-01), None
patent: WO-00/35887 (2000-06-01), None
patent: WO-01/97848 (2001-12-01), None
patent: WO-02/060524 (2002-08-01), None
Anderson et al., Magn. Reson. Med. (2000) 44:433-439.
Haubner et al., J. Nucl. Med. (1999) 40:1061-1071.
Haubner et al., J. Nucl. Med. (2001) 42:326-336.
Kerr et al., Anticancer Res. (1999) 19:959-968.
Sipkins et al., Nature Med. (1998) 4:623-626.
Storgard et al., J. Clin. Invest. (1999) 103:47-53.
Winter et al., Circulation (2002) 106(19):II-151 (Abstracts from Scientific Sessions).
Supplementary Partial European Search Report for EP 03707550.4, mailed on Jul. 12, 2006, 5 pages.
Goodman et al., Journal of Medicinal Chemistry (2002) 45(5):1045-1051.
Harris Tom
Lanza Gregory M.
Wickline Samuel A.
Barnes-Jewish Hospital
Bristol-Myers Squibb Medical Imaging, Inc.
Jones D. L.
LandOfFree
Integrin targeted imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrin targeted imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin targeted imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3977430